Press release
Organoids Market Outlook: Analyzing Industry Trends, Growth Factors, and Forecasts for 2031
The Insight Partners is pleased to announce the release of its comprehensive report on the Global Organoids Market, providing a detailed survey of the current state of the industry. This report offers essential insights, including definitions, classifications, applications, and the industry chain structure.Download Sample PDF: https://www.theinsightpartners.com/sample/TIPRE00017616/?utm_source=OpenPR&utm_medium=10310
Key Highlights:
• Market Overview: A thorough analysis of the global Organoids market, including historical development, competitive landscape, and the status of major regions.
• Key Players: Notable companies profiled in the report include STEMCELL Technologies; Molecular Devices, LLC.; HUB Organoids B.V. (Hubrecht Organoid Technology); DefiniGEN; Organoid Therapeutics; Thermo Fisher Scientific Inc.; Corning Inc.; Merck KGaA; InSphero; ACRO Biosystems; and Bio-Techne Corporation
• Growth Strategies: The report highlights both organic and inorganic growth strategies employed by market players, such as product launches, acquisitions, partnerships, and collaborations.
Market Segmentation and Insights: The report includes a SWOT analysis of key companies, macro-economic indicators, and a detailed forecast based on various segments across five major regions: North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA), and South & Central America. Each region is further segmented by country and specific market segments.
Organoids Market Drivers and Opportunities
Surging Adoption of Personalized Medicine
The growing trend towards personalized medicine is significantly boosting the organoids market. Personalized medicine tailors treatment plans to individual patients based on their specific responses or disease risks. A report from the Personalized Medicine Coalition highlights that the share of personalized medicines among new FDA-approved molecular entities increased from 5% in 2005 to over 25% in 2016. In 2022, 12 out of 37 new molecular entities (approximately 34%) approved by the FDA were personalized medicines.
Furthermore, biopharmaceutical companies have ramped up their R&D investments in personalized drugs, with projections indicating a 33% increase by 2027. Research suggests a potential 69% growth in personalized medicine development in the coming years. The number of personalized medicines in the U.S. market also rose from 132 in 2016 to 286 in 2020, reflecting a robust demand that will further drive organoid applications in drug development.
Focus on Drug Discovery
The escalating need for innovative drugs is propelling drug discovery activities, thereby creating more opportunities for the organoids market. According to ClinicalTrials.gov, there were approximately 384,288 clinical trials registered in 2021. A survey by HUB indicates that organoids can help streamline drug discovery by identifying patients unlikely to benefit from certain treatments, potentially reducing clinical trial costs.
Organoids are versatile tools not only for cancer research but also for studying various diseases such as cystic fibrosis, polycystic kidney disease, and more. They can effectively mimic organ properties-structure and function-and restore the genetic state of tissues, making them valuable for gene editing and other therapeutic developments. As drug discovery continues to evolve, the demand for advanced technologies like organoid models will increase, presenting substantial growth opportunities for the market.
Get Full Copy of This Report: https://www.theinsightpartners.com/buy/TIPRE00017616/?utm_source=OpenPR&utm_medium=10310
For inquiries, please contact: Ankit Mathur
Phone: +1-646-491-9876
E-mail: sales@theinsightpartners.com
The Insight Partners is your one-stop research provider for actionable intelligence, specializing in various industries, including Healthcare, Technology, and Manufacturing.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Organoids Market Outlook: Analyzing Industry Trends, Growth Factors, and Forecasts for 2031 here
News-ID: 3716392 • Views: …
More Releases from The Insight Partners

Future of Clean Energy - Complete Guide (PDF)
With the mounting population and industrialization, the demand for energy is also rising at the global level. This has boosted the need for alternative energy sources, as traditional energy resources such as fossil fuels are directing to environmental pollution. Clean alternative options such as solar and wind curb immense carbon emissions and their negative impact on the environment and help balance the energy supply and demand. Thus, the rise in…

Mechanical Thrombectomy Devices Market Size, Demand, Share, Analysis with Focus …
An off-the-shelf report on Mechanical Thrombectomy Devices Market which has been compiled after an in-depth analysis of the market trends prevailing across five geographies (North America, Europe, Asia-Pacific, Middle-East and Africa, and South America). Various segments of the market such as type/components/ application/industry verticals/ end-users are analyzed with robust research methodology which includes three step process starting with extensive secondary research to gather data from company profiles, global/regional associations, trade…

Containment Piping System Market Size, Demand, Analytical Overview, Comprehensiv …
Containment Piping System Market study by "The Insight Partners" provides details about the market dynamics affecting the market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favorable competitive landscape and trends prevailing over the years. This Report encloses comprehensive analysis on the market and are assessed through volume and value data validated on three approaches including top companies' revenues. It concludes with precise and…

Nutraceuticals - An Ultimate PDF Guide
Consumers in developed and some developing countries are highly attracted to functional products, mainly on account of the added health and wellness benefits. Nutraceuticals are associated with various medicinal and health benefits, such as to improve the function of the immune system, boost gut health, and others. Rising healthcare costs, coupled with the increasing geriatric population across the world, propels the adoption of various nutraceuticals such as dietary supplements, functional…
More Releases for Organoid
4Dcell Achieves 95% Organoid Reproducibility Breakthrough With Patented Anchorin …
4Dcell announced that its SmartSphero plates have achieved over 95% reproducibility in organoid size and shape, while reducing organoid loss during medium exchanges to below 12%, a significant improvement over the 86% loss seen in traditional unanchored systems. This breakthrough addresses a persistent challenge in pharmaceutical drug screening and safety testing, where inconsistent organoid cultures have often hindered data reliability.
The company's patented Anchoring Point Technology (APT®) allows researchers to culture…
Organoid Culture Medium Research:the global Organoid Culture Medium market size …
QY Research Inc. (Global Market Report Research Publisher) announces the release of 2025 latest report "Organoid Culture Medium- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031". Based on current situation and impact historical analysis (2020-2024) and forecast calculations (2025-2031), this report provides a comprehensive analysis of the global Wire Drawing Dies market, including market size, share, demand, industry development status, and forecasts for the next few years.
…
Organoid Technology Market Size, Growth, In-depth Analysis, Research Report Fore …
The organoid technology market is estimated to grow at a CAGR of 27.12% during the forecast period.
The prime factors propelling the growth of the organoid technology market are increasing demand for personalized medicine, drug discovery and development, and regenerative medicine.
As per the report, the organoid technology market is expected to grow rapidly during the forecast period.
Organoids are three-dimensional cell cultures that mimic the structure and function of human organs, making…
Organoid Technology Market Trends, Future Demands, Growth Factors, Emerging Tech …
The global Organoids and Spheroids Market size was valued at $516.6 million in 2021 and is projected to reach $1.2 billion by 2031, growing at a CAGR of 8.5% from 2022 to 2031.
Organoid technology bridges the gap between conventional two-dimensional cell line culture and in vivo models. The near-physiological technology can virtually recapitulates organ development and human diseases, such as infectious diseases, genetic abnormality and even cancers.
Between traditional two-dimensional cell…
Organoids Market Driven By Definigen, Organoid Therapeutics, Hubrecht Organoid T …
The scope of the organoids market includes type, application, source, and region. The organoids market is analyzed based on regions, such as North America, Europe, Asia Pacific, Middle East & Africa, and South and Central America. The report offers insights and in-depth analysis of the organoids market emphasizing on various parameters, such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.…
Organoids Market Witness Heightened Revenue of US$ 3,420.40 million by 2027 with …
The Organoids Market was valued at US$ 689.47 million in 2019 and it is projected to reach US$ 3,420.40 million by 2027; it is expected to grow at a CAGR of 22.1% from 2020 to 2027.
Organoids are tiny, self-organized three-dimensional tissue cultures that are derived from stem cells. Such cultures can be crafted to replicate much of the complexity of an organ, or to express selected aspects of it like…